Type 2 diabetes remission: a systematic review and meta-analysis of nonsurgical randomized controlled trials
Sherifali DT, Racey ME, Greenway MK, et al.
Diabetes Care. Pub. online 22 Sep 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Trends in type 1 diabetes incidence between 2007 and 2023 and their association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years old in Sweden
Dietler D, Björk J, Palmkvist E, Carlsson A
Diabetologia. Pub. online 18 Sep 2025.
Leggi
Is type 2 diabetes a modifiable risk factor for the evolution and progression of heart failure with a preserved ejection fraction?
Packer M, Lam CSP, Butler J, et al.
J Am Coll Cardiol. Pub. online 17 Sep 2025.
Leggi
Impact of baseline GLP-1 receptor agonist use on albuminuria reduction and safety with simultaneous initiation of finerenone and empagliflozin in type 2 diabetes and chronic kidney disease (CONFIDENCE Trial)
Agarwal R, Green JB, Heerspink HJL, et al.
Diabetes Care. Pub. online 19 Sep 2025.
Leggi
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council
Giorgino F, Alzaid F, Pantea Stoian A, et al.
Diabetologia. Pub. online 10 Sep 2025.
Leggi
Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: a randomized controlled trial
Thammakosol K, Jantarapootirat M, Traiwanatham S, Sriphrapradang C
Diabetes Obes Metab. Pub. online 3 Sep 2025.
Leggi
Mobile app-based intervention and cardiovascular risk factors in patients with uncontrolled type 2 diabetes: a randomized clinical trial
Zhang PZ, Guo D, Liu CQ, et al.
JAMA Netw Open. Pub. online 2 Sep 2025.
Leggi
Semaglutide treatment of antipsychotic-treated patients with schizophrenia, prediabetes, and obesity: the HISTORI randomized clinical trial
Ganeshalingam AA, Uhrenholt N, Arnfred S, et al.
JAMA Psychiatry. Pub. online 3 Sep 2025.
Leggi
Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis
de Visser HS, Waraich S, Chhabra M, et al.
JAMA Pediatr. Pub. online 8 Sep 2025.
Leggi
Clinical features modifying the cardiovascular benefits of GLP-1 receptor agonists: a systematic review and meta-analysis
Kalayci A, Januzzi JL, Mitsunami M, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 31 Aug 2025.
Leggi